104 related articles for article (PubMed ID: 18366462)
1. Kinetics of inactivating human parvovirus B19 and porcine parvovirus by dry-heat treatment.
Blümel J; Stühler A; Dichtelmüller H
Transfusion; 2008 Apr; 48(4):790. PubMed ID: 18366462
[No Abstract] [Full Text] [Related]
2. Dry-heat sensitivity of human B19 and porcine parvoviruses.
Prikhod'ko GG
Transfusion; 2005 Oct; 45(10):1692-3. PubMed ID: 16181226
[No Abstract] [Full Text] [Related]
3. Inactivation of parvovirus B19 and model viruses in factor VIII by dry heat treatment at 80 degrees C.
Roberts PL; El Hana C; Saldana J
Transfusion; 2006 Sep; 46(9):1648-50; author reply 1650. PubMed ID: 16965597
[No Abstract] [Full Text] [Related]
4. Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
Hattori S; Yunoki M; Tsujikawa M; Urayama T; Tachibana Y; Yamamoto I; Yamamoto S; Ikuta K
Vox Sang; 2007 Feb; 92(2):121-4. PubMed ID: 17298573
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of parvovirus B19 during pasteurization of human serum albumin.
Blümel J; Schmidt I; Willkommen H; Löwer J
Transfusion; 2002 Aug; 42(8):1011-8. PubMed ID: 12385412
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations.
Yunoki M; Urayama T; Tsujikawa M; Sasaki Y; Abe S; Takechi K; Ikuta K
Br J Haematol; 2005 Feb; 128(3):401-4. PubMed ID: 15667545
[TBL] [Abstract][Full Text] [Related]
7. Removal of small non-enveloped viruses by nanofiltration.
Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T
Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526
[TBL] [Abstract][Full Text] [Related]
8. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
[TBL] [Abstract][Full Text] [Related]
10. Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid-heating.
Tsujikawa M; Nishigaki H; Yoshikawa M; Furuki R; Takahashi K; Adan-Kubo J; Shimamura Y; Urayama T; Hattori S; Sakai K; Yunoki M; Ikuta K
Vox Sang; 2012 Feb; 102(2):93-9. PubMed ID: 21781123
[TBL] [Abstract][Full Text] [Related]
11. Heat stability of parvovirus B19: kinetics of inactivation.
Schwarz TF; Serke S; Von Brunn A; Hottenträger B; Huhn D; Deinhardt F; Roggendorf M
Zentralbl Bakteriol; 1992 Jul; 277(2):219-23. PubMed ID: 1520981
[TBL] [Abstract][Full Text] [Related]
12. Cell culture-based assay of parvovirus B19 and the relevance of animal model viruses.
Blümel J
Dev Biol (Basel); 2004; 118():107-12. PubMed ID: 15645679
[TBL] [Abstract][Full Text] [Related]
13. Heat sensitivity of human parvovirus B19.
Yunoki M; Tsujikawa M; Urayama T; Sasaki Y; Morita M; Tanaka H; Hattori S; Takechi K; Ikuta K
Vox Sang; 2003 Apr; 84(3):164-9. PubMed ID: 12670364
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
[TBL] [Abstract][Full Text] [Related]
15. Placental endothelial cells can be productively infected by Parvovirus B19.
Pasquinelli G; Bonvicini F; Foroni L; Salfi N; Gallinella G
J Clin Virol; 2009 Jan; 44(1):33-8. PubMed ID: 19058999
[TBL] [Abstract][Full Text] [Related]
16. Testing thermal resistance of viruses.
Sauerbrei A; Wutzler P
Arch Virol; 2009; 154(1):115-9. PubMed ID: 19039515
[TBL] [Abstract][Full Text] [Related]
17. A laboratory study of survival of selected microorganisms after heat treatment of biowaste used in biogas plants.
Sahlström L; Bagge E; Emmoth E; Holmqvist A; Danielsson-Tham ML; Albihn A
Bioresour Technol; 2008 Nov; 99(16):7859-65. PubMed ID: 18513960
[TBL] [Abstract][Full Text] [Related]
18. B19 parvovirus withstands "super heating" in antihemophilic concentrates.
Morfini M; Azzi A; Mannucci PM
Thromb Haemost; 1996 Nov; 76(5):821. PubMed ID: 8950802
[No Abstract] [Full Text] [Related]
19. No influence of collagenous proteins of Achilles tendon, skin and cartilage on the virus-inactivating efficacy of peracetic acid-ethanol.
Scheffler S; Trautmann S; Smith M; Kalus U; von Versen R; Pauli G; Pruss A
Biologicals; 2007 Oct; 35(4):355-9. PubMed ID: 17644408
[TBL] [Abstract][Full Text] [Related]
20. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.
Roberts PL; Dunkerley C; McAuley A; Winkelman L
Vox Sang; 2007 Jan; 92(1):56-63. PubMed ID: 17181591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
